ABBV vs AMGN — Key Metrics

Metric ABBV (ABBVIE INC) AMGN (AMGEN INC)
Price286.01443.89
Market Cap505.56 Billion240.11 Billion
P/E (TTM)49.0625.54
P/B (Quarterly)-109.23518.033
P/S (TTM)7.666.17
Net Profit Margin (TTM)15.724.1
Gross Margin (TTM)73.770.9
ROE (TTM)-201.085.6
Revenue Growth YoY (TTM)n/an/a

Upfront Investment - S&P 500 Stock Comparison & AI Analysis

AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.

ABBVIE INC
vs
 
AMGEN INC
 
ABBVIE INC
vs
 
AMGEN INC
Performance Comparison
AI Model Recommendation
ABBV · ABBVIE INC

Outperform

44
UnderperformOutperform
AMGN · AMGEN INC

Outperform

38
UnderperformOutperform
Recommendation Summary

Both stocks are projected to outperform the market over the next year. If you have to make a choice, Upfront Recommendation: ABBV.

Financial Metrics
Prices delayed ~15 min
ABBV Metrics AMGN
$286.01 Price $443.89
— Market Capitalization —
49.06 Price to Earnings Ratio 25.54
7.66 Price to Sales 6.17
26.79 Price to FCF Ratio 25.06
10.39 Price to Gross Profit 8.7
50.75 Price to R&D 30.63
13.49 Price to Current Assets 6.99

ABBV vs AMGN at a glance

Abbvie INC (ABBV) and Amgen INC (AMGN) are both Drug Manufacturers - General companies in the Healthcare sector. ABBV is the larger, at $505.6 billion in market value against $240.1 billion for AMGN, about 2.1 times the size.

On trailing-twelve-month figures, ABBV trades at 49.1 times trailing earnings and AMGN at 25.5; net profit margins are 15.7% and 24.1%.

The Upfront Investment model currently rates both Outperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.